Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹3,342 Cr₹1,858 Cr₹3,665 Cr₹3,101 Cr₹2,572 Cr

What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS is ₹3,342 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹3,342 Cr
Mar2024₹1,858 Cr
Mar2023₹3,665 Cr
Mar2022₹3,101 Cr
Mar2021₹2,572 Cr

How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2025 ₹3,342 Cr
79.83
Mar2024 ₹1,858 Cr
-49.30
Mar2023 ₹3,665 Cr
18.19
Mar2022 ₹3,101 Cr
20.57
Mar2021 ₹2,572 Cr -

Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,614.6 Cr -1% -3.7% 32.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,210.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 5.9% -3.7% -6.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1%

-3.7%

32.7%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses